These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22460435)

  • 1. [Research in pharmacoepidemiology in Iceland].
    Johannsson M; Haraldsdottir S
    Laeknabladid; 2012 Apr; 98(4):217-22. PubMed ID: 22460435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nordic countries as a cohort for pharmacoepidemiological research.
    Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
    ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
    [No Abstract]   [Full Text] [Related]  

  • 5. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
    Luo X; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
    Becher H; Kostev K; Schröder-Bernhardi D
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):617-26. PubMed ID: 19825325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
    Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepidemiology and Drug Safety's special issue on validation studies.
    Chun DS; Lund JL; Stürmer T
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):123-125. PubMed ID: 30714240
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods for safety signal detection in healthcare databases: a literature review.
    Arnaud M; Bégaud B; Thurin N; Moore N; Pariente A; Salvo F
    Expert Opin Drug Saf; 2017 Jun; 16(6):721-732. PubMed ID: 28490262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Odense Pharmacoepidemiological Database: A Review of Use and Content.
    Hallas J; Hellfritzsch M; Rix M; Olesen M; Reilev M; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):419-425. PubMed ID: 28164442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance based on prescription databases.
    Gram LE; Hallas J; Andersen M
    Pharmacol Toxicol; 2000; 86 Suppl 1():13-5. PubMed ID: 10905747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.
    Fukazawa C; Hinomura Y; Kaneko M; Narukawa M
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1402-1408. PubMed ID: 30324671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.
    Luo X; Doherty J; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 Nov; 23(11):2607-15. PubMed ID: 17854515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacoepidemiology. Analysis of drug prescription data].
    Gothe H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1145-54. PubMed ID: 18985408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; Guillo S; Foulon S; Tubach F
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):372-7. PubMed ID: 26781227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs.
    Larsen MD; Cars T; Hallas J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):13-8. PubMed ID: 22901097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
    Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan.
    Ishiguro C; Takeuchi Y; Uyama Y; Tawaragi T
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):854-9. PubMed ID: 27222073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.